Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chromium supplement tame blood sugar before problems start?

NCT ID NCT07711587

Not yet recruiting Disease control Sponsor: Standard Process Inc. Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This pilot study tests whether a daily dietary supplement called Diaplex can improve how the body handles blood sugar in healthy adults aged 30 to 65 who have mildly elevated glucose levels. Over 16 weeks, participants receive either Diaplex or a placebo, and researchers measure insulin sensitivity and blood sugar patterns using continuous glucose monitors. The goal is to gather preliminary data on safety and effectiveness to guide larger future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement called Diaplex, which contains chromium and other ingredients
What this could lead to
If it works, this could point toward a natural supplement for managing early blood sugar elevations in otherwise healthy people.
What could go wrong
This is a small, early pilot study with only 40 participants, so results may not be conclusive or apply to everyone. The supplement may show no benefit over placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELEVATED BLOOD GLUCOSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT INSULIN SENSITIVITY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.